Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben J Boado

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2011
Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitorQing-Hui Zhou, Rachita Sumbria, Eric Ka-Wai Hui, et al.
Brain Research|July 6, 2010
Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrierAiling Fu, Qing-Hui Zhou, Eric Ka-Wai Hui, et al.
Molecular Pharmaceutics|February 16, 2013
Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in miceRachita K Sumbria, Qing-Hui Zhou, Eric Ka-Wai Hui, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 30, 2019
Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 miceJiahong Sun, Joshua Yang, Kathrine Whitman, et al.
Molecular Pharmaceutics|May 19, 2017
Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's DiseaseRudy Chang, Jillian Knox, Jae Chang, et al.
Orphanet Journal of Rare Diseases|July 7, 2018
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trialRoberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 18, 2012
Immunologic privilege in the central nervous system and the blood-brain barrierLeslie L Muldoon, Jorge I Alvarez, David J Begley, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2011
Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitorQing-Hui Zhou, Rachita Sumbria, Eric Ka-Wai Hui, et al.
Brain Research|July 6, 2010
Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrierAiling Fu, Qing-Hui Zhou, Eric Ka-Wai Hui, et al.
Molecular Pharmaceutics|February 16, 2013
Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in miceRachita K Sumbria, Qing-Hui Zhou, Eric Ka-Wai Hui, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 30, 2019
Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 miceJiahong Sun, Joshua Yang, Kathrine Whitman, et al.
Molecular Pharmaceutics|May 19, 2017
Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's DiseaseRudy Chang, Jillian Knox, Jae Chang, et al.
Orphanet Journal of Rare Diseases|July 7, 2018
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trialRoberto Giugliani, Luciana Giugliani, Fabiano de Oliveira Poswar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 18, 2012
Immunologic privilege in the central nervous system and the blood-brain barrierLeslie L Muldoon, Jorge I Alvarez, David J Begley, et al.
Pageof 10